FI935065A0 - Farmaceutiska foereningar - Google Patents
Farmaceutiska foereningarInfo
- Publication number
- FI935065A0 FI935065A0 FI935065A FI935065A FI935065A0 FI 935065 A0 FI935065 A0 FI 935065A0 FI 935065 A FI935065 A FI 935065A FI 935065 A FI935065 A FI 935065A FI 935065 A0 FI935065 A0 FI 935065A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical production
- pharmaceutical
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9224169 | 1992-11-18 | ||
GB929224169A GB9224169D0 (en) | 1992-11-18 | 1992-11-18 | Pharmaceutical compounds |
GB9302367 | 1993-02-06 | ||
GB939302367A GB9302367D0 (en) | 1993-02-06 | 1993-02-06 | Pharmaceutical compounds |
Publications (4)
Publication Number | Publication Date |
---|---|
FI935065A0 true FI935065A0 (fi) | 1993-11-16 |
FI935065A FI935065A (fi) | 1994-05-19 |
FI103727B1 FI103727B1 (fi) | 1999-08-31 |
FI103727B FI103727B (fi) | 1999-08-31 |
Family
ID=26301995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935065A FI103727B (fi) | 1992-11-18 | 1993-11-16 | Menetelmä terapeuttisesti käyttökelpoisten 2-amino-4-substioitu-fenyyli-4H-pyrano£3,2-h|kinoliini-3-karbonitriilien valmistamiseksi |
Country Status (16)
Country | Link |
---|---|
US (1) | US5434160A (fi) |
EP (2) | EP0599514A3 (fi) |
JP (1) | JPH06199862A (fi) |
KR (1) | KR940011465A (fi) |
CN (1) | CN1040982C (fi) |
AU (1) | AU668602B2 (fi) |
CA (1) | CA2103203A1 (fi) |
CO (1) | CO4130335A1 (fi) |
CZ (1) | CZ243493A3 (fi) |
FI (1) | FI103727B (fi) |
HU (1) | HU9303261D0 (fi) |
IL (1) | IL107627A (fi) |
NO (1) | NO304890B1 (fi) |
NZ (1) | NZ250195A (fi) |
PL (1) | PL301059A1 (fi) |
TW (1) | TW289755B (fi) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9306062D0 (en) * | 1993-03-24 | 1993-05-12 | Lilly Industries Ltd | Pharmaceutical compounds |
FR2795071B1 (fr) * | 1999-06-16 | 2001-07-27 | Adir | Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
SI1230232T1 (en) | 1999-11-05 | 2004-08-31 | Cytovia, Inc. | Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
US7015328B2 (en) | 2001-05-16 | 2006-03-21 | Cytovia, Inc. | Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
US6858607B1 (en) | 2001-05-16 | 2005-02-22 | Cytovia, Inc. | 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
ES2337558T3 (es) | 2001-05-16 | 2010-04-27 | Cytovia, Inc. | 4-h-cromenos sustituidos y analagos como activadores de caspasas e inductores de apoptosis y uso como agentes anticancerigenos. |
CN100349887C (zh) * | 2002-05-16 | 2007-11-21 | 西托维亚公司 | 取代的4-芳基-4h-吡咯并[2,3-h]色烯和类似物及其药物组合物和用途 |
WO2003096982A2 (en) | 2002-05-16 | 2003-11-27 | Cytovia, Inc. | Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
KR20070100878A (ko) | 2004-09-09 | 2007-10-12 | 하워드 플로리 인스티튜트 오브 익스페러멘틀 피지알러지 앤드 메디신 | 효소 억제제 및 그 용도 |
US7843312B2 (en) * | 2006-12-12 | 2010-11-30 | Honeywell International Inc. | Wireless control of security system with key-operated key fob |
US8263775B2 (en) | 2007-11-19 | 2012-09-11 | Howard Florey Institute | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof |
JP5926272B2 (ja) * | 2010-11-12 | 2016-05-25 | ドイチェス クレブスフォルシュンクスツェントルム | Wnt経路のアンタゴニストとしてのクロメン誘導体及びそれらの類似体 |
WO2023099589A1 (en) * | 2021-12-01 | 2023-06-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Irap inhibitors for use in the treatment of inflammatory diseases |
CN115028643B (zh) * | 2022-06-10 | 2024-03-22 | 中国药科大学 | 吡喃并喹啉衍生物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4243674A (en) * | 1978-06-12 | 1981-01-06 | Pfizer Inc. | 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore |
JPS61502124A (ja) * | 1984-05-09 | 1986-09-25 | ジ オ−ストラリアン ナシヨナル ユニヴア−シテイ− | 免疫応答の調節方法 |
JP2631710B2 (ja) * | 1988-08-16 | 1997-07-16 | 日本ヘキスト・マリオン・ルセル株式会社 | ピラノ〔f〕キノリノン誘導体及び該化合物を有効成分とする医薬組成物 |
US4931221A (en) * | 1988-12-30 | 1990-06-05 | Ppg Industries, Inc. | Photochromic spiropyran compounds |
US5284868A (en) * | 1991-10-09 | 1994-02-08 | Eli Lilly And Company | Pharmaceutical compounds |
GB9306062D0 (en) * | 1993-03-24 | 1993-05-12 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1993
- 1993-11-11 EP EP19930308999 patent/EP0599514A3/en not_active Ceased
- 1993-11-11 EP EP99204310A patent/EP1004584A3/en not_active Withdrawn
- 1993-11-12 US US08/150,945 patent/US5434160A/en not_active Expired - Fee Related
- 1993-11-15 TW TW082109528A patent/TW289755B/zh active
- 1993-11-15 AU AU50671/93A patent/AU668602B2/en not_active Ceased
- 1993-11-15 CZ CZ932434A patent/CZ243493A3/cs unknown
- 1993-11-15 PL PL93301059A patent/PL301059A1/xx unknown
- 1993-11-15 NZ NZ250195A patent/NZ250195A/en unknown
- 1993-11-16 NO NO934145A patent/NO304890B1/no not_active IP Right Cessation
- 1993-11-16 KR KR1019930024262A patent/KR940011465A/ko not_active Application Discontinuation
- 1993-11-16 IL IL107627A patent/IL107627A/xx not_active IP Right Cessation
- 1993-11-16 CA CA002103203A patent/CA2103203A1/en not_active Abandoned
- 1993-11-16 FI FI935065A patent/FI103727B/fi active
- 1993-11-17 HU HU9303261A patent/HU9303261D0/hu unknown
- 1993-11-17 CN CN93115028A patent/CN1040982C/zh not_active Expired - Fee Related
- 1993-11-17 CO CO93418738A patent/CO4130335A1/es unknown
- 1993-11-17 JP JP5287139A patent/JPH06199862A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1004584A2 (en) | 2000-05-31 |
PL301059A1 (en) | 1994-05-30 |
IL107627A (en) | 1997-04-15 |
TW289755B (fi) | 1996-11-01 |
EP1004584A3 (en) | 2000-07-05 |
NO934145L (no) | 1994-05-19 |
CO4130335A1 (es) | 1995-02-13 |
CA2103203A1 (en) | 1994-05-19 |
NZ250195A (en) | 1995-12-21 |
EP0599514A2 (en) | 1994-06-01 |
KR940011465A (ko) | 1994-06-21 |
FI103727B1 (fi) | 1999-08-31 |
IL107627A0 (en) | 1994-02-27 |
US5434160A (en) | 1995-07-18 |
HU9303261D0 (en) | 1994-03-28 |
EP0599514A3 (en) | 1994-07-06 |
FI935065A (fi) | 1994-05-19 |
CN1092072A (zh) | 1994-09-14 |
AU5067193A (en) | 1994-06-02 |
FI103727B (fi) | 1999-08-31 |
NO304890B1 (no) | 1999-03-01 |
JPH06199862A (ja) | 1994-07-19 |
AU668602B2 (en) | 1996-05-09 |
CZ243493A3 (en) | 1994-06-15 |
NO934145D0 (no) | 1993-11-16 |
CN1040982C (zh) | 1998-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942923L (no) | Medikamenter | |
FI930882A (fi) | Farmaceutiska foereningar | |
DE69330973D1 (de) | Vielseitig verwendbares Produktionssystem | |
FI921060A (fi) | Farmaceutiska aerosolformuleringar | |
FI922958A (fi) | Farmaceutisk sammansaettning | |
FI922252A (fi) | Farmaceutisk sammansaettning | |
FI922316A (fi) | Farmaceutisk sammansaettning | |
FI923581A (fi) | Farmaceutisk kombinationsformation | |
DK0616523T3 (da) | Lægemidler | |
DK229489A (da) | Laegemiddeladsorbater | |
DE69301826D1 (de) | Bildherstellung | |
NO923859D0 (no) | Medikament | |
NO931831D0 (no) | Farmasoeytiske blandinger | |
FI935065A (fi) | Farmaceutiska foereningar | |
FI931251A (fi) | Farmaceutiska foereningar | |
DK86492D0 (da) | Laegemiddel | |
FI955605A0 (fi) | Aryloivia lääkkeitä | |
FI921786A (fi) | Farmaceutisk foerening | |
DK138592D0 (da) | Tabletter | |
FI921785A (fi) | Farmaceutisk foerening | |
FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
FI934317A0 (fi) | Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen | |
DK137192D0 (da) | Laegemiddel/-plante | |
TH13625EX (th) | เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท | |
DK7190D0 (da) | Laegemiddel |